Editas Medicine, Inc.·4

Jul 21, 4:30 PM ET

Mei Baisong 4

4 · Editas Medicine, Inc. · Filed Jul 21, 2023

Insider Transaction Report

Form 4
Period: 2023-07-19
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Transactions
  • Sale

    Common Stock

    2023-07-19$8.80/sh4,317$37,99072,055 total
Footnotes (1)
  • [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 14, 2022 and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 18, 2023. The sale does not represent a discretionary trade by the Reporting Person.

Documents

1 file
  • 4
    form4-07212023_040701.xmlPrimary